← Every applicant
Pai Holdings FDA Approvals
6 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| GLYCEROL PHENYLBUTYRATENew drugJul 28, 2026LIQUID, ORAL |
| PROPRANOLOL HYDROCHLORIDENew drugJun 10, 2026SOLUTION, ORAL |
| LACTULOSENew drugMar 14, 2025FOR SOLUTION, ORAL |
| SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATENew drugJul 15, 2024SOLUTION, ORAL |
| ATOVAQUONENew drugOct 25, 2021SUSPENSION, ORAL |
| OXCARBAZEPINENew drugJul 9, 2021SUSPENSION, ORAL |